Oxymorphone Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DRRX | D | DURECT Corporation | -1.47 | |
COLL | B | Collegium Pharmaceutical, Inc. | -1.23 |
Related Industries: Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | D | PowerShares Dynamic Biotech & Genome | 2.86 | |
SIXS | C | 6 Meridian Small Cap Equity ETF | 2.31 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 1.98 | |
PILL | C | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 1.54 | |
SFLO | C | VictoryShares Small Cap Free Cash Flow ETF | 1.25 |
Compare ETFs
- Oxymorphone
Oxymorphone, sold under the brand names Numorphan among others, is a powerful semi-synthetic opioid analgesic (painkiller) developed in Germany in 1914. Pain relief after injection begins after about 5–10 minutes and 15–30 minutes after rectal administration, and lasts about 3–4 hours for immediate-release tablets and 12 hours for extended-release tablets.It is highly addictive and in June 2017 the FDA asked the manufacturer to remove its product from the US market. This was in part due to the opioid epidemic in the US, and the fact that the 2012 reformulation led to a shift in the route of abuse from nasal to injection. It was the first time in the history of the agency, that the FDA had made a request for removal regarding a product currently on the market. In response, by July 2017, Endo International voluntarily removed Opana ER from the market. Generic versions of extended release oxymorphone are still available for prescription use in the US.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles